Detalhe da pesquisa
1.
Transient acute kidney injury after chimeric antigen receptor T-cell therapy in patients with hematological malignancies.
Clin Kidney J
; 17(3): sfae027, 2024 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-38500492
2.
Recent Bendamustine Treatment Before Apheresis Has a Negative Impact on Outcomes in Patients With Large B-Cell Lymphoma Receiving Chimeric Antigen Receptor T-Cell Therapy.
J Clin Oncol
; 42(2): 205-217, 2024 Jan 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-37874957
3.
Torque Teno Virus plasma DNA load: a novel prognostic biomarker in CAR-T therapy.
Bone Marrow Transplant
; 59(1): 93-100, 2024 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-37919456
4.
Adenovirus-induced hemorrhagic cystitis after CD19-targeted chimeric antigen receptor T-cell therapy in a patient with large B-cell lymphoma.
Immunotherapy
; 15(16): 1369-1374, 2023 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-37718888
5.
PET-based radiomics signature can predict durable responses to CAR T-cell therapy in patients with large B-cell lymphoma.
EJHaem
; 4(4): 1081-1088, 2023 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-38024636
6.
Is estimated exposure an accurate surrogate for measured fludarabine levels in patients with CAR T-cell therapy?
Blood Adv
; 8(9): 2130-2132, 2024 May 14.
Artigo
em Inglês
| MEDLINE | ID: mdl-38231085